Thibaut du Fayet
Vorstandsvorsitzender bei PHAXIAM THERAPEUTICS S.A.
Aktive Positionen von Thibaut du Fayet
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHAXIAM THERAPEUTICS S.A. | Vorstandsvorsitzender | 23.06.2023 | - |
Karriereverlauf von Thibaut du Fayet
Ehemalige bekannte Positionen von Thibaut du Fayet
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STALLERGENES | Vertrieb & Marketing | 01.01.2007 | 01.01.2008 |
BIOMÉRIEUX | Vertrieb & Marketing | - | - |
PHERECYDES PHARMA | Vorstandsvorsitzender | 15.12.2022 | - |
Geschäftsführer | 07.04.2022 | 19.05.2022 | |
Corporate Officer/Principal | 19.05.2022 | - | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Direktor/Vorstandsmitglied | - | - |
TRANSGENE | Corporate Officer/Principal | - | - |
Vertrieb & Marketing | 01.01.2008 | - |
Ausbildung von Thibaut du Fayet
ESSEC Business School | Masters Business Admin |
Brandeis University | Graduate Degree |
Statistik
International
Frankreich | 7 |
Vereinigte Staaten | 2 |
China | 2 |
Operativ
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
TRANSGENE | Health Technology |
BIOMÉRIEUX | Health Technology |
PHAXIAM THERAPEUTICS S.A. | Health Technology |
Private Unternehmen | 3 |
---|---|
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
- Börse
- Insiders
- Thibaut du Fayet
- Erfahrung